Regulus Therapeutics
RGLS
#8773
Rank
NZ$0.21 B
Marketcap
$3.17
Share price
-0.83%
Change (1 day)
-26.89%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2023 (TTM): -$2.78

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.00. In 2022 the company made an earnings per share (EPS) of -$3.31 an increase over its 2021 EPS that were of -$5.81.

EPS history for Regulus Therapeutics from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.78-15.88%
2022-$3.31-43.12%
2021-$5.81-40.55%
2020-$9.77-50%
2019-$19.55-80.36%
2018-$99.52-57.8%
2017-$235.84-28.66%
2016-$330.5642.2%
2015-$232.46-14.84%
2014-$272.98156%
2013-$106.63-98.75%
2012-$8,533

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$6.22-307.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
$5.65-288.18%๐Ÿ‡ซ๐Ÿ‡ท France
$32.81-1,192.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.53-217.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$7.30 143.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.56-14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.06-334.91%๐Ÿ‡บ๐Ÿ‡ธ USA